Here are three things Rite Aid (RAD) will need to do if it hopes to successfully compete against CVS (CVS) and Walgreen (WAG)
Rite Aid (RAD -20.53%) shares have more than quadrupled in the past year thanks to restructuring its debt, closing unprofitable stores, boosting generic scripts, and broadening its immunization services.
If Rite Aid hopes to continue its recovery and challenge CVS (CVS -1.32%) and Walgreen (WBA -0.80%) it will need to execute on the three important initiatives I highlight in the following slideshow.
Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool recommends CVS Caremark. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
